How Much Does Harvoni Cost?

Our most recent US pharmacy data shows a low of roughly $11,738.00 for Harvoni with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.

We found Canadian pricing for Harvoni starting near $13.66 per tablet in USD terms. That's before any shipping charge, which the table above breaks out separately.

Drug pricing is set separately in each country through different negotiation, regulatory, and distribution systems, so the same medication can legitimately carry different price tags on either side of the border. Check the comparison table above for the specific numbers on Harvoni.

Generic and brand-name pricing for Harvoni is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

The out-of-pocket cost for Harvoni with insurance depends entirely on the specific details of your plan, including your deductible, copay, and coinsurance requirements. While insurance significantly reduces the overall cost, your share can still be considerable. It's beneficial to compare your plan's copay against prices available through pharmacy savings programs or discount cards, which might offer an alternative rate. Always verify with your pharmacy about their acceptance of such savings options for this medication.

Harvoni is generally covered under Medicare Part D prescription drug plans and certain Medicare Advantage plans. The patient's cost share can vary widely, from a standard copay to a percentage of the drug's cost, potentially ranging from tens to thousands of dollars depending on coverage phase. It's important for beneficiaries to review their plan's formulary and cost structure. Comparing your Medicare copay to prices available through other pharmacy discount programs can sometimes reveal additional savings opportunities.

Yes. The active ingredients in Harvoni, ledipasvir and sofosbuvir, are available in a generic formulation simply called ledipasvir-sofosbuvir. This generic version is manufactured after the brand-name patent expires and typically offers a lower-cost alternative for treating chronic hepatitis C.